Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ranolazine: effects on ischemic heart.
Rognoni A, Barbieri L, Cavallino C, Bacchini S, Veia A, Degiovanni A, Rametta F, Nardi F, Lazzero M, Lupi A, Bongo AS. Rognoni A, et al. Among authors: lazzero m. Recent Pat Cardiovasc Drug Discov. 2013 Dec;8(3):197-203. doi: 10.2174/15748901113089990023. Recent Pat Cardiovasc Drug Discov. 2013. PMID: 23961914 Review.
Levosimendan: from basic science to clinical trials.
Rognoni A, Lupi A, Lazzero M, Bongo AS, Rognoni G. Rognoni A, et al. Among authors: lazzero m. Recent Pat Cardiovasc Drug Discov. 2011 Jan;6(1):9-15. doi: 10.2174/157489011794578455. Recent Pat Cardiovasc Drug Discov. 2011. PMID: 21208157 Review.
Update on glycoprotein IIb/IIIa: role in primary coronary intervention.
Rognoni A, Lupi A, Secco GG, Cavallino C, Sansa M, Lazzero M, Bongo AS. Rognoni A, et al. Among authors: lazzero m. Cardiovasc Hematol Agents Med Chem. 2011 Apr 1;9(2):106-12. doi: 10.2174/187152511796196524. Cardiovasc Hematol Agents Med Chem. 2011. PMID: 21574947 Review.
Pharmacological adjuvant therapies in primary coronary interventions: bivalirudin.
Lupi A, Rognoni A, Cavallino C, Secco GG, Prando MD, Santagostino M, Lazzero M, Cassetti E, Bongo AS. Lupi A, et al. Among authors: lazzero m. Cardiovasc Hematol Agents Med Chem. 2013 Jun;11(2):106-14. doi: 10.2174/1871525711311020006. Cardiovasc Hematol Agents Med Chem. 2013. PMID: 22963495 Review.
Comparison of the novel Angio-Seal Evolution with Angio-Seal STS closure device.
Lupi A, Rognoni A, Secco GG, Lazzero M, Plebani L, Cossa G, Reale D, Sansa M, Bongo AS, Di Mario C. Lupi A, et al. Among authors: lazzero m. Perspect Vasc Surg Endovasc Ther. 2012 Mar;24(1):28-36. doi: 10.1177/1531003512442091. Epub 2012 Apr 3. Perspect Vasc Surg Endovasc Ther. 2012. PMID: 22491159
Drug eluting balloon versus drug eluting stent in percutaneous coronary interventions: insights from a meta-analysis of 1462 patients.
Lupi A, Rognoni A, Secco GG, Porto I, Nardi F, Lazzero M, Rossi L, Parisi R, Fattori R, Genoni G, Rosso R, Stella PR, Sheiban I, Bolognese L, Liistro F, Bongo AS, Agostoni P. Lupi A, et al. Among authors: lazzero m. Int J Cardiol. 2013 Oct 12;168(5):4608-16. doi: 10.1016/j.ijcard.2013.07.161. Epub 2013 Jul 26. Int J Cardiol. 2013. PMID: 23948110
23 results